Drug response in organoids generated from frozen primary tumor tissues

por Walsh, Alex J., Cook, Rebecca S., Sanders, Melinda E., Arteaga, Carlos L., Skala, Melissa C.
Publicado 2016

Author Correction: Drug response in organoids generated from frozen primary tumor tissues

por Walsh, Alex J., Cook, Rebecca S., Sanders, Melinda E., Arteaga, Carlos L., Skala, Melissa C.
Publicado 2019

Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow up

por Sanders, Melinda E., Schuyler, Peggy A., Simpson, Jean F., Page, David L., Dupont, William D.
Publicado 2014

Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy

por Castellanos, Emily H., Feld, Emily, Estrada, Monica V., Sanders, Melinda E., Massion, Pierre P., Johnson, Douglas B., Balko, Justin M., Horn, Leora
Publicado 2017

Tissue-specific expression of p73 and p63 isoforms in human tissues

por Marshall, Clayton B., Beeler, J. Scott, Lehmann, Brian D., Gonzalez-Ericsson, Paula, Sanchez, Violeta, Sanders, Melinda E., Boyd, Kelli L., Pietenpol, Jennifer A.
Publicado 2021

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

por Lehmann, Brian D., Jovanović, Bojana, Chen, Xi, Estrada, Monica V., Johnson, Kimberly N., Shyr, Yu, Moses, Harold L., Sanders, Melinda E., Pietenpol, Jennifer A.
Publicado 2016

Precision of Multiple Reaction Monitoring Mass Spectrometry Analysis of Formalin-Fixed, Paraffin-Embedded Tissue

por Sprung, Robert W., Martinez, Misti A., Carpenter, Kristen L., Ham, Amy-Joan L., Washington, Mary Kay, Arteaga, Carlos L., Sanders, Melinda E., Liebler, Daniel C.
Publicado 2012

Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2

por Luo, Na, Formisano, Luigi, Gonzalez-Ericsson, Paula I., Sanchez, Violeta, Dean, Phillip T., Opalenik, Susan R., Sanders, Melinda E., Cook, Rebecca S., Arteaga, Carlos L., Johnson, Douglas B., Balko, Justin M.
Publicado 2018

p73 regulates epidermal wound healing and induced keratinocyte programming

por Beeler, J. Scott, Marshall, Clayton B., Gonzalez-Ericsson, Paula I., Shaver, Timothy M., Santos Guasch, Gabriela L., Lea, Spencer T., Johnson, Kimberly N., Jin, Hailing, Venters, Bryan J., Sanders, Melinda E., Pietenpol, Jennifer A.
Publicado 2019

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

por Lehmann, Brian D, Bauer, Joshua A, Schafer, Johanna M, Pendleton, Christopher S, Tang, Luojia, Johnson, Kimberly C, Chen, Xi, Balko, Justin M, Gómez, Henry, Arteaga, Carlos L, Mills, Gordon B, Sanders, Melinda E, Pietenpol, Jennifer A
Publicado 2014

DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer

por Luo, Na, Nixon, Mellissa J., Gonzalez-Ericsson, Paula I., Sanchez, Violeta, Opalenik, Susan R., Li, Huili, Zahnow, Cynthia A., Nickels, Michael L., Liu, Fei, Tantawy, Mohammed N., Sanders, Melinda E., Manning, H. Charles, Balko, Justin M.
Publicado 2018

Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer

por Hanna, Ann, Nixon, Mellissa J., Estrada, M. Valeria, Sanchez, Violeta, Sheng, Quanhu, Opalenik, Susan R., Toren, Abigail L., Bauer, Joshua, Owens, Phillip, Mason, Frank M., Cook, Rebecca S., Sanders, Melinda E., Arteaga, Carlos L., Balko, Justin M.
Publicado 2022

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance

por James, Jamaal L, Taylor, Brandie C, Axelrod, Margaret L, Sun, Xiaopeng, Guerin, Lindsey N, Gonzalez-Ericsson, Paula I, Wang, Yu, Sanchez, Violeta, Fahey, Catherine, Sanders, Melinda E, Xu, Yaomin, Hodges, Emily, Johnson, Douglas B, Balko, Justin M
Publicado 2023

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

por Lehmann, Brian D., Colaprico, Antonio, Silva, Tiago C., Chen, Jianjiao, An, Hanbing, Ban, Yuguang, Huang, Hanchen, Wang, Lily, James, Jamaal L., Balko, Justin M., Gonzalez-Ericsson, Paula I., Sanders, Melinda E., Zhang, Bing, Pietenpol, Jennifer A., Chen, X. Steven
Publicado 2021

PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer

por Nixon, Mellissa J., Formisano, Luigi, Mayer, Ingrid A., Estrada, M. Valeria, González-Ericsson, Paula I., Isakoff, Steven J., Forero-Torres, Andrés, Won, Helen, Sanders, Melinda E., Solit, David B., Berger, Michael F., Cantley, Lewis C., Winer, Eric P., Arteaga, Carlos L., Balko, Justin M.
Publicado 2019

Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer

por Lee, Kyung-min, Guerrero-Zotano, Angel L., Servetto, Alberto, Sudhan, Dhivya R., Lin, Chang-Ching, Formisano, Luigi, Jansen, Valerie M., González-Ericsson, Paula, Sanders, Melinda E., Stricker, Thomas P., Raj, Ganesh, Dean, Kevin M., Fiolka, Reto, Cantley, Lewis C., Hanker, Ariella B., Arteaga, Carlos L.
Publicado 2020

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC

por Franklin, Derek A., Sharick, Joe T., Ericsson-Gonzalez, Paula I., Sanchez, Violeta, Dean, Phillip T., Opalenik, Susan R., Cairo, Stefano, Judde, Jean-Gabriel, Lewis, Michael T., Chang, Jenny C., Sanders, Melinda E., Cook, Rebecca S., Skala, Melissa C., Bordeaux, Jennifer, Orozco Bender, Jehovana, Vaupel, Christine, Geiss, Gary, Hinerfeld, Douglas, Balko, Justin M.
Publicado 2020

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

por Johnson, Douglas B., Estrada, Monica V., Salgado, Roberto, Sanchez, Violeta, Doxie, Deon B., Opalenik, Susan R., Vilgelm, Anna E., Feld, Emily, Johnson, Adam S., Greenplate, Allison R., Sanders, Melinda E., Lovly, Christine M., Frederick, Dennie T., Kelley, Mark C., Richmond, Ann, Irish, Jonathan M., Shyr, Yu, Sullivan, Ryan J., Puzanov, Igor, Sosman, Jeffrey A., Balko, Justin M.
Publicado 2016

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

por Finotello, Francesca, Mayer, Clemens, Plattner, Christina, Laschober, Gerhard, Rieder, Dietmar, Hackl, Hubert, Krogsdam, Anne, Loncova, Zuzana, Posch, Wilfried, Wilflingseder, Doris, Sopper, Sieghart, Ijsselsteijn, Marieke, Brouwer, Thomas P., Johnson, Douglas, Xu, Yaomin, Wang, Yu, Sanders, Melinda E., Estrada, Monica V., Ericsson-Gonzalez, Paula, Charoentong, Pornpimol, Balko, Justin, de Miranda, Noel Filipe da Cunha Carvahlo, Trajanoski, Zlatko
Publicado 2019

Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

por Finotello, Francesca, Mayer, Clemens, Plattner, Christina, Laschober, Gerhard, Rieder, Dietmar, Hackl, Hubert, Krogsdam, Anne, Loncova, Zuzana, Posch, Wilfried, Wilflingseder, Doris, Sopper, Sieghart, Ijsselsteijn, Marieke, Brouwer, Thomas P., Johnson, Douglas, Xu, Yaomin, Wang, Yu, Sanders, Melinda E., Estrada, Monica V., Ericsson-Gonzalez, Paula, Charoentong, Pornpimol, Balko, Justin, da Cunha Carvalho de Miranda, Noel Filipe, Trajanoski, Zlatko
Publicado 2019